It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Universal access to childhood vaccination is important to child health and sustainable development. Here we identify, at a fine spatial scale, under-immunized children and zero-dose children. Using Chad, as an example, the most recent nationally representative household survey that included recommended vaccine antigens was assembled. Age-disaggregated population (12–23 months) and vaccination coverage were modelled at a fine spatial resolution scale (1km × 1 km) using a Bayesian geostatistical framework adjusting for a set of parsimonious covariates. There was a variation at fine spatial scale in the population 12–23 months a national mean of 18.6% (CrI 15.8%–22.6%) with the highest proportion in the South-East district of Laremanaye 20.0% (14.8–25.0). Modelled coverage at birth was 49.0% (31.2%–75.3%) for BCG, 44.8% (27.1–74.3) for DTP1, 24.7% (12.5–46.3) for DTP3 and 47.0% (30.6–71.0) for measles (MCV1). Combining coverage estimates with the modelled population at a fine spatial scale yielded 312,723 (Lower estimate 156055–409266) zero-dose children based on DTP1. Improving routine immunization will require investment in the health system as part of enhancing primary health care. The uncertainties in our estimates highlight areas that require further investigation and higher quality data to gain a better understanding of vaccination coverage.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 WHO Regional Office for Africa, Brazzaville, Congo (GRID:grid.463718.f) (ISNI:0000 0004 0639 2906)
2 WHO Headquarters, Geneva, Switzerland (GRID:grid.3575.4) (ISNI:0000000121633745)